SCHEMBL15617567

SCHEMBL15617567

CCC1OC(n2cnc(C(C)=O)n2)C(O)C1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.61
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ TSHR P16473 2/20 0.61
▸ THPO P40225 2/20 0.61
▸ PMP22 Q01453 2/20 0.61
▸ GLA P06280 1/20 0.61
▸ EIF4E P06730 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ TOP1 P11387 1/20 0.61
▸ ADORA1 P30542 1/20 0.61
▸ PNP P00491 3/20 0.54
▸ ADK P55263 2/20 0.38
▸ ATG7 O95352 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ BLM P54132 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13352082 0.89 LMNA (0.76) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL12901991 0.89 LMNA (0.76) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL13320541 0.89 LMNA (0.76) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL13320671 0.89 LMNA (0.76) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL2845582 0.89 LMNA (0.76) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL15019611 0.88 LMNA (0.79) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL12150452 0.88 LMNA (0.79) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL14108533 0.88 LMNA (0.79) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL17752031 0.86 LMNA (0.57) LMNASMN1; SMN2ALDH1A1TSHRTHPO
SCHEMBL17232112 0.86 LMNA (0.57) LMNASMN1; SMN2ALDH1A1TSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8679472-B1 Crystal of human interferon alpha 2B in complex with zinc Merck, Sharp & Dohme Corp. (US) 2014-03-25 — — US disclosed
Send feedback